In the ten years since its creation, CrossMab technology has grown to become one of the most sophisticated, adaptable, and extensively applied technologies in the field of bispecific antibodies. With 16 of them still undergoing evaluation in ongoing clinical trials, at least 19 bispecific antibodies and fusion proteins based on CrossMab technology created by Roche and other businesses had entered clinical trials as of mid-2021. The most developed of them are the bispecific antibodies directed against CD20/CD3 T cells, glofitamab, which is presently in a pivotal phase 3 study, and Ang-2/VEGF, faricimab, which is presently undergoing regulatory review.
Website: https://www.creative-biola...

Jewel of india one of the best option for your dinner. Because they are providing you indian food dishes like Garlic Naan, Chicken Tikka Masala, Samosa, Plain Rice, Royal Biryani and much more items if you eat then visit our Jewel of india Restaurant.

https://jewelofindiawa.com...

https://youtu.be/qfuRuvqra...
If you are interested in calming, relaxing music and sounds feel free to check this video out and subscribe to the channel for more videos 💕💕
I would really appreciate it if you subscribed and more than grateful to you 💕 #relax #lofi #music #vibe